Received May 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 3 | 945664 | IM / RA |
Patient is 16 years old. Was given Heplisav B which is indicated for patients 18 years and older. Did not experience any adverse event or side effects per mother.